Literature DB >> 21054662

Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoea.

C Paschke1, N Apelt, E Fleischmann, P Perona, C Walentiny, T Löscher, K-H Herbinger.   

Abstract

Diarrhoea is the most frequent health problem among travellers in the tropics. However, data on the spectrum and relevance of enteropathogens in international travellers with and without diarrhoea are limited. Stool samples from 114 cases of diarrhoea in travellers returning from the tropics were collected for microbiological examination and PCR for norovirus genogroups I and II, enteroaggregative Escherichia coli (EAEC), and enterotoxigenic E. coli (ETEC) producing heat-labile toxin (LT) and heat-stable toxin (ST). Travel and laboratory data of cases were compared with those of 56 travellers without diarrhoea. Among cases, EAEC was found in 45% of stool samples, followed by LT-ETEC (20%), ST-ETEC (16%), Blastocystis hominis (15%), Campylobacter jejuni (12%), norovirus (11%), Giardia lamblia (6%), Shigella spp. (6%), and Salmonella spp., Cryptosporidium spp., and Cyclospora cayetanensis (3% each). However, only for EAEC, ST-ETEC, Blastocystis and Campylobacter was the prevalence significantly higher among cases than among controls. Co-infections were common: 61% for cases and 13% for controls. The most common travel destination was Asia (54%), followed by Africa (35%) and Latin America (9%). The highest relative risk for diarrhoea was calculated for travellers to West Africa, East Africa, and South Asia. In this study, EAEC, LT-ETEC and ST-ETEC were detected most frequently in cases of travellers' diarrhoea. Although enteric infections with EAEC, ST-ETEC and Campylobacter often cause diarrhoea, the pathogenetic relevance remains unclear for most of the other enteropathogens, because of significant prevalence rates also being seen in controls without diarrhoea and the high frequency of co-infections.
© 2010 The Authors. Clinical Microbiology and Infection © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054662     DOI: 10.1111/j.1469-0691.2010.03414.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  25 in total

Review 1.  Epidemiology and clinical manifestations of enteroaggregative Escherichia coli.

Authors:  Betina Hebbelstrup Jensen; Katharina E P Olsen; Carsten Struve; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 2.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

3.  Spectrum of Imported Infectious Diseases: A Comparative Prevalence Study of 16,817 German Travelers and 977 Immigrants from the Tropics and Subtropics.

Authors:  Karl-Heinz Herbinger; Martin Alberer; Nicole Berens-Riha; Mirjam Schunk; Gisela Bretzel; Frank von Sonnenburg; Hans Dieter Nothdurft; Thomas Löscher; Marcus Beissner
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

4.  Locals get travellers' diarrhoea too: risk factors for diarrhoeal illness and pathogenic Escherichia coli infection across an urban-rural gradient in Ecuador.

Authors:  Shanon M Smith; Lorena Montero; Maritza Paez; Estefania Ortega; Eric Hall; Kate Bohnert; Xavier Sanchez; Edison Puebla; Pablo Endara; William Cevallos; Gabriel Trueba; Karen Levy
Journal:  Trop Med Int Health       Date:  2018-12-06       Impact factor: 2.622

5.  Epidemiological, clinical, and diagnostic data on intestinal infections with Entamoeba histolytica and Entamoeba dispar among returning travelers.

Authors:  K-H Herbinger; E Fleischmann; C Weber; P Perona; T Löscher; G Bretzel
Journal:  Infection       Date:  2011-06-30       Impact factor: 3.553

6.  Elevated Values of C-Reactive Protein Induced by Imported Infectious Diseases: A Controlled Cross-Sectional Study of 11,079 Diseased German Travelers Returning from the Tropics and Subtropics.

Authors:  Karl-Heinz Herbinger; Ingrid Hanus; Mirjam Schunk; Marcus Beissner; Frank von Sonnenburg; Thomas Löscher; Gisela Bretzel; Michael Hoelscher; Hans Dieter Nothdurft; Kristina Lydia Huber
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

7.  Prevalence of enteroaggregative Escherichia coli and its virulence-related genes in a case-control study among children from north-eastern Brazil.

Authors:  Ila Fernanda Nunes Lima; Nadia Boisen; Josiane da Quetz Silva; Alexandre Havt; Eunice Bobo de Carvalho; Alberto Melo Soares; Noélia Leal Lima; Rosa Maria Salani Mota; James P Nataro; Richard Littleton Guerrant; Aldo Ângelo Moreira Lima
Journal:  J Med Microbiol       Date:  2013-02-21       Impact factor: 2.472

8.  Lymphocytosis and Lymphopenia Induced by Imported Infectious Diseases: A Controlled Cross-Sectional Study of 17,229 Diseased German Travelers Returning from the Tropics and Subtropics.

Authors:  Karl-Heinz Herbinger; Ingrid Hanus; Marcus Beissner; Nicole Berens-Riha; Inge Kroidl; Frank von Sonnenburg; Thomas Löscher; Michael Hoelscher; Hans Dieter Nothdurft; Mirjam Schunk
Journal:  Am J Trop Med Hyg       Date:  2016-04-11       Impact factor: 2.345

9.  Blastocystis spp. and Giardia intestinalis co-infection profile in children suffering from acute diarrhea.

Authors:  Doaa Ahmed Hamdy; Wegdan Mohamed Abd El Wahab; Shaimaa Ahmed Senosy; Amna Gouda Mabrouk
Journal:  J Parasit Dis       Date:  2019-10-08

10.  Phylogenetic Analysis of Enteroaggregative Escherichia coli (EAEC) Isolates from Japan Reveals Emergence of CTX-M-14-Producing EAEC O25:H4 Clones Related to Sequence Type 131.

Authors:  Naoko Imuta; Tadasuke Ooka; Kazuko Seto; Ryuji Kawahara; Toyoyasu Koriyama; Tsuyoshi Kojyo; Atsushi Iguchi; Koichi Tokuda; Hideki Kawamura; Kiyotaka Yoshiie; Yoshitoshi Ogura; Tetsuya Hayashi; Junichiro Nishi
Journal:  J Clin Microbiol       Date:  2016-06-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.